Palmitate-Stimulated Monocytes Induce Adhesion Molecule Expression in Endothelial Cells via IL-1 Signaling Pathway

Journal of Cellular Physiology

Volumn 230, Issue 3, 2015, Pages 732-742

  Shikama, Yosuke ^a   Aki, Nanako ^a,b   Hata, Akiko ^a   Nishimura, Miho ^a   Oyadomari, Seiichi ^b   Funaki, Makoto ^a  

^a TOKUSHIMA UNIVERSITY HOSPITAL   (Japan)

^b UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; FATTY ACID; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1; INTERLEUKIN 1BETA; PALMITIC ACID; PHORBOL 13 ACETATE 12 MYRISTATE; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; UNSATURATED FATTY ACID; CELL ADHESION MOLECULE; PALMITIC ACID DERIVATIVE; PHORBOL; PHORBOL DERIVATIVE;

ARTICLE; CELL SURFACE; CONTROLLED STUDY; CYTOKINE RELEASE; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; LEUKOCYTE ADHERENCE; MONOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UPREGULATION; BIOSYNTHESIS; DRUG EFFECTS; GENE EXPRESSION REGULATION; METABOLISM;

CELL ADHESION MOLECULES; E-SELECTIN; ENDOTHELIAL CELLS; GENE EXPRESSION REGULATION; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-1; MONOCYTES; PALMITATES; PHORBOLS; SIGNAL TRANSDUCTION;

EID: 84920885356     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.24797     Document Type: Article

References (53)

1. Alessio M, De Monte L, Scirea A, Gruarin P, Tandon NN, Sitia R. 1996. Synthesis, processing, and intracellular transport of CD36 during monocytic differentiation. J Biol Chem 271:1770-1775.
2. Anderson EK, Hill AA, Hasty AH. 2012. Stearic acid accumulation in macrophages induces toll-like receptor 4/2-independent inflammation leading to endoplasmic reticulum stress-mediated apoptosis. Arterioscler Thromb Vasc Biol 32:1687-1695.
3. Arend WP. 2002. The balance between IL-1 and IL-1Ra in disease. Cytokine Growth Factor Rev 13:323-340.
4. Arend WP, Smith MF, Jr., Janson RW, Joslin FG. 1991. IL-1 receptor antagonist and IL-1 beta production in human monocytes are regulated differently. J Immunol 147:1530-1536.
5. Babina M, Henz BM. 2003. All-trans retinoic acid down-regulates expression and function of beta2 integrins by human monocytes: Opposite effects on monocytic cell lines. Eur J Immunol 33:616-625.
6. Buler M, Aatsinki SM, Skoumal R, Komka Z, Toth M, Kerkela R, Georgiadi A, Kersten S, Hakkola J. 2012. Energy-sensing factors coactivator peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1alpha) and AMP-activated protein kinase control expression of inflammatory mediators in liver: Induction of interleukin 1 receptor antagonist. J Biol Chem 287:1847-1860.
7. Campbell SE, Tandon NN, Woldegiorgis G, Luiken JJ, Glatz JF, Bonen A. 2004. A novel function for fatty acid translocase (FAT)/CD36: Involvement in long chain fatty acid transfer into the mitochondria-involvement in long chain fatty acid transfer into the mitochondria. J Biol Chem 279:36235-36241.
8. Charles MA, Eschwege E, Thibult N, Claude JR, Warnet JM, Rosselin GE, Girard J, Balkau B. 1997. The role of non-esterified fatty acids in the deterioration of glucose tolerance in Caucasian subjects: Results of the Paris Prospective Study. Diabetologia 40:1101-1106.
9. Cipolletta C, Ryan KE, Hanna EV, Trimble ER. 2005. Activation of peripheral blood CD14+ monocytes occurs in diabetes. Diabetes 54:2779-2786.
10. Daigneault M, Preston JA, Marriott HM, Whyte MK, Dockrell DH. 2010. The identification of markers of macrophage differentiation in PMA-stimulated THP-1 cells and monocyte-derived macrophages. PLoS ONE 5: e8668.
11. Di Angelantonio E, Sarwar N, Perry P, Kaptoge S, Ray KK, Thompson A, Wood AM, Lewington S, Sattar N, Packard CJ, Collins R, Thompson SG, Danesh J. 2009. Major lipids, apolipoproteins, and risk of vascular disease. JAMA 302:1993-2000.
12. Dinarello CA. 1997. Interleukin-1. Cytokine Growth Factor Rev 8:253-265.
13. Ehses JA, Lacraz G, Giroix MH, Schmidlin F, Coulaud J, Kassis N, Irminger JC, Kergoat M, Portha B, Homo-Delarche F, Donath MY. 2009. IL-1 antagonism reduces hyperglycemia and tissue inflammation in the type 2 diabetic GK rat. Proc Nat Acad Sci USA 106:13998-14003.
14. Erridge C, Samani NJ. 2009. Saturated fatty acids do not directly stimulate Toll-like receptor signaling. Arterioscler Thromb Vasc Biol 29:1944-1949.
15. Haraldsen G, Kvale D, Lien B, Farstad IN, Brandtzaeg P. 1996. Cytokine-regulated expression of E-selectin, intercellular adhesion molecule-1 (ICAM-1), and vascular cell adhesion molecule-1 (VCAM-1) in human microvascular endothelial cells. J Immunol 156:2558-2565.
16. Harvey KA, Walker CL, Pavlina TM, Xu Z, Zaloga GP, Siddiqui RA. 2010. Long-chain saturated fatty acids induce pro-inflammatory responses and impact endothelial cell growth. Clin Nutr 29:492-500.
17. Hodson L, Skeaff CM, Fielding BA. 2008. Fatty acid composition of adipose tissue and blood in humans and its use as a biomarker of dietary intake. Prog Lipid Res 47:348-380.
18. Hoogerbrugge N, Verkerk A, Jacobs ML, Postema PT, Jongkind JF. 1996. Hypertriglyceridemia enhances monocyte binding to endothelial cells in NIDDM. Diabetes Care 19:1122-1125.
19. Hoogeveen RC, Ballantyne CM, Bang H, Heiss G, Duncan BB, Folsom AR, Pankow JS. 2007. Circulating oxidised low-density lipoprotein and intercellular adhesion molecule-1 and risk of type 2 diabetes mellitus: The Atherosclerosis Risk in Communities Study. Diabetologia 50:36-42.
20. Hwang SJ, Ballantyne CM, Sharrett AR, Smith LC, Davis CE, Gotto AM, Jr., Boerwinkle E. 1997. Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: The Atherosclerosis Risk in Communities (ARIC) study. Circulation 96:4219-4225.
21. Isoda K, Sawada S, Ayaori M, Matsuki T, Horai R, Kagata Y, Miyazaki K, Kusuhara M, Okazaki M, Matsubara O, Iwakura Y, Ohsuzu F. 2005. Deficiency of interleukin-1 receptor antagonist deteriorates fatty liver and cholesterol metabolism in hypercholesterolemic mice. J Biol Chem 280:7002-7009.
22. Johnston WF, Salmon M, Su G, Lu G, Stone ML, Zhao Y, Owens GK, Upchurch GR, Jr., Ailawadi G. 2013. Genetic and pharmacologic disruption of interleukin-1beta signaling inhibits experimental aortic aneurysm formation. Arterioscler Thromb Vasc Biol 33:294-304.
23. Kim F, Pham M, Luttrell I, Bannerman DD, Tupper J, Thaler J, Hawn TR, Raines EW, Schwartz MW. 2007. Toll-like receptor-4 mediates vascular inflammation and insulin resistance in diet-induced obesity. Circ Res 100:1589-1596.
24. Kirii H, Niwa T, Yamada Y, Wada H, Saito K, Iwakura Y, Asano M, Moriwaki H, Seishima M. 2003. Lack of interleukin-1beta decreases the severity of atherosclerosis in ApoE-deficient mice. Arterioscler Thromb Vasc Biol 23:656-660.
25. Kohro T, Tanaka T, Murakami T, Wada Y, Aburatani H, Hamakubo T, Kodama T. 2004. A comparison of differences in the gene expression profiles of phorbol 12-myristate 13-acetate differentiated THP-1 cells and human monocyte-derived macrophage. J Atheroscler Thromb 11:88-97.
26. Kwon B, Lee HK, Querfurth HW. 2014. Oleate prevents palmitate-induced mitochondrial dysfunction, insulin resistance and inflammatory signaling in neuronal cells. Biochim Biophys Acta 1843:1402-1413.
27. L'Homme L, Esser N, Riva L, Scheen A, Paquot N, Piette J, Legrand-Poels S. 2013. Unsaturated fatty acids prevent activation of NLRP3 inflammasome in human monocytes/macrophages. J Lipid Res 54:2998-3008.
28. Lacoste L, Lam JY, Hung J, Letchacovski G, Solymoss CB, Waters D. 1995. Hyperlipidemia and coronary disease. Correction of the increased thrombogenic potential with cholesterol reduction. Circulation 92:3172-3177.
29. Leeuwenberg JF, Smeets EF, Neefjes JJ, Shaffer MA, Cinek T, Jeunhomme TM, Ahern TJ, Buurman WA. 1992. E-selectin and intercellular adhesion molecule-1 are released by activated human endothelial cells in vitro. Immunology 77:543-549.
30. Maedler K, Sergeev P, Ris F, Oberholzer J, Joller-Jemelka HI, Spinas GA, Kaiser N, Halban PA, Donath MY. 2002. Glucose-induced beta cell production of IL-1beta contributes to glucotoxicity in human pancreatic islets. J Clin Invest 110:851-860.
31. Maloney E, Sweet IR, Hockenbery DM, Pham M, Rizzo NO, Tateya S, Handa P, Schwartz MW, Kim F. 2009. Activation of NF-kappaB by palmitate in endothelial cells: A key role for NADPH oxidase-derived superoxide in response to TLR4 activation. Arterioscler Thromb Vasc Biol 29:1370-1375.
32. Nomura S, Takahashi N, Inami N, Kajiura T, Yamada K, Nakamori H, Tsuda N. 2004. Probucol and ticlopidine: Effect on platelet and monocyte activation markers in hyperlipidemic patients with and without type 2 diabetes. Atherosclerosis 174:329-335.
33. Pou J, Martinez-Gonzalez J, Rebollo A, Rodriguez C, Rodriguez-Calvo R, Martin-Fuentes P, Cenarro A, Civeira F, Laguna JC, Alegret M. 2011. Type II interleukin-1 receptor expression is reduced in monocytes/macrophages and atherosclerotic lesions. Biochim Biophys Acta 1811:556-563.
34. Poutsiaka DD, Clark BD, Vannier E, Dinarello CA. 1991. Production of interleukin-1 receptor antagonist and interleukin-1 beta by peripheral blood mononuclear cells is differentially regulated. Blood 78:1275-1281.
35. Richieri GV, Kleinfeld AM. 1995. Unbound free fatty acid levels in human serum. J Lipid Res 36:229-240.
36. Riserus U, Willett WC, Hu FB. 2009. Dietary fats and prevention of type 2 diabetes. Prog Lipid Res 48:44-51.
37. Sampson MJ. 2002. Monocyte and neutrophil adhesion molecule expression during acute hyperglycemia and after antioxidant treatment in type 2 diabetes and control patients. Arterioscler Thromb Vasc Biol 22:1187-1193.
38. Shi H, Kokoeva MV, Inouye K, Tzameli I, Yin H, Flier JS. 2006. TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest 116:3015-3025.
39. Shikama Y, Ishimaru N, Kudo Y, Bando Y, Aki N, Hayashi Y, Funaki M. 2013. Effects of free fatty acids on human salivary gland epithelial cells. J Dent Res 92:540-546.
40. Snodgrass RG, Huang S, Choi IW, Rutledge JC, Hwang DH. 2013. Inflammasome-mediated secretion of IL-1beta in human monocytes through TLR2 activation; modulation by dietary fatty acids. J Immunol 191:4337-4347.
41. Springer TA. 1994. Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm. Cell 76:301-314.
42. Steinberg HO, Tarshoby M, Monestel R, Hook G, Cronin J, Johnson A, Bayazeed B, Baron AD. 1997. Elevated circulating free fatty acid levels impair endothelium-dependent vasodilation. J Clin Invest 100:1230-1239.
43. Szekanecz Z, Shah MR, Pearce WH, Koch AE. 1994. Intercellular adhesion molecule-1 (ICAM-1) expression and soluble ICAM-1 (sICAM-1) production by cytokine-activated human aortic endothelial cells: A possible role for ICAM-1 and sICAM-1 in atherosclerotic aortic aneurysms. Clin Exp Immunol 98:337-343.
44. Takahashi M, Ikeda U, Masuyama J, Kitagawa S, Kasahara T, Shimpo M, Kano S, Shimada K. 1996. Monocyte-endothelial cell interaction induces expression of adhesion molecules on human umbilical cord endothelial cells. Cardiovasc Res 32:422-429.
45. Thorand B, Baumert J, Chambless L, Meisinger C, Kolb H, Doring A, Lowel H, Koenig W. 2006. Elevated markers of endothelial dysfunction predict type 2 diabetes mellitus in middle-aged men and women from the general population. Arterioscler Thromb Vasc Biol 26:398-405.
46. Vaddi K, Newton RC. 1994. Comparison of biological responses of human monocytes and THP-1 cells to chemokines of the intercrine-beta family. J Leukoc Biol 55:756-762.
47. Van Tassell BW, Toldo S, Mezzaroma E, Abbate A. 2013. Targeting interleukin-1 in heart disease. Circulation 128:1910-1923.
48. von der Thusen, Kuiper JH, van Berkel J, Biessen TJ. 2003. Interleukins in atherosclerosis: Molecular pathways and therapeutic potential. Pharmacol Rev 55:133-166.
49. Waki H, Yamauchi T, Kamon J, Kita S, Ito Y, Hada Y, Uchida S, Tsuchida A, Takekawa S, Kadowaki T. 2005. Generation of globular fragment of adiponectin by leukocyte elastase secreted by monocytic cell line THP-1. Endocrinology 146:790-796.
50. Woollard KJ, Geissmann F. 2010. Monocytes in atherosclerosis: Subsets and functions. Nat Rev Cardiol 7:77-86.
51. Wu KK, Aleksic N, Ballantyne CM, Ahn C, Juneja H, Boerwinkle E. 2003. Interaction between soluble thrombomodulin and intercellular adhesion molecule-1 in predicting risk of coronary heart disease. Circulation 107:1729-1732.
52. Yang B. 2003. Pharmacokinetics of anakinra in subjects with different levels of renal function. Clin Pharmacol Ther 74:85-94.
53. Zhang WY, Schwartz E, Wang Y, Attrep J, Li Z, Reaven P. 2006. Elevated concentrations of nonesterified fatty acids increase monocyte expression of CD11b and adhesion to endothelial cells. Arterioscler Thromb Vasc Biol 26:514-519.